Welcome to LookChem.com Sign In|Join Free
The company logo of Chengdu Henghui Pharmaceutical Co., Ltd.(expird)

Chengdu Henghui Pharmaceutical Co., Ltd.(expird)

Free supplier Enterprise Certification

Free
supplier
8th
years

Chengdu Henghui Pharmaceutical Co., Ltd.(expird)

Business Type:Lab/Research institutions

Audited Supplier

Main Products:
Year Established:
2017

Search in the shop

  • Search in the shop
  • Search the station
Home>>Products>>Pexidartinib

Products Categories

Product Certification&
Enterprise Certification

More Detail

Chengdu Henghui Pharmaceutical Co., Ltd.(expird)

Country: China (Mainland)

Business Type:Lab/Research institutions

Pexidartinib

CAS NO.1029044-16-3

  • Min.Order: 1 Gram
  • Payment Terms:
Contact Supplier

Product Details

Keywords

  • Pexidartinib
  • PLX-3397
  • high purity and best price

Quick Details

  • ProName: Pexidartinib
  • CasNo: 1029044-16-3
  • Molecular Formula: C20H15ClF3N5
  • Appearance: white powder
  • Application: For laboratory use only- not intended ...
  • DeliveryTime: 2 Weeks
  • ProductionCapacity: 1 Kilogram/Week
  • Purity: ≥98%
  • Storage: room temperature
  • Transportation: by air
  • LimitNum: 1 Gram

Superiority

We are a CRO company, and our Research and Development team is consisted of PhDs and Masters in chemistry and pharmacy.

We are committed to protect our customer’s privacy with the highest level of ethical standard. Our dedicated team will follow up on every order and provide instant feedback on the status to our customer.

We stand behind our product by providing a complete QA report. The test data of customer order can be provided upon request.

We make our efforts to offer customer innovative, customized, high-quality service.

Our custom manufacturing encompasses everything from pharmaceutical intermediates to API.

 

 

 

Details

Pexidartinib is a receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3, with potential antineoplastic activity, with IC50 of 28 and 16 nM for Fms and Kit, respectively. IC50 & Target: IC50: 28 nM (c-Fms), 16 nM (c-Kit) In Vivo:Pexidartinib is a potent drug for treatment of cancer and used for Phase III TGCT clinical trial

lookchemhot productCASNew CAS Cas Database Article Data Chemical Catalog
Hot Product
Contact Supplier